295 related articles for article (PubMed ID: 12934066)
1. Body language: the function of PML nuclear bodies in apoptosis regulation.
Hofmann TG; Will H
Cell Death Differ; 2003 Dec; 10(12):1290-9. PubMed ID: 12934066
[TBL] [Abstract][Full Text] [Related]
2. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
3. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
[TBL] [Abstract][Full Text] [Related]
4. PML nuclear bodies and apoptosis.
Takahashi Y; Lallemand-Breitenbach V; Zhu J; de Thé H
Oncogene; 2004 Apr; 23(16):2819-24. PubMed ID: 15077145
[TBL] [Abstract][Full Text] [Related]
5. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
7. Regulation of apoptosis by PML and the PML-NBs.
Bernardi R; Papa A; Pandolfi PP
Oncogene; 2008 Oct; 27(48):6299-312. PubMed ID: 18931695
[TBL] [Abstract][Full Text] [Related]
8. Regulation of p53 activity in nuclear bodies by a specific PML isoform.
Fogal V; Gostissa M; Sandy P; Zacchi P; Sternsdorf T; Jensen K; Pandolfi PP; Will H; Schneider C; Del Sal G
EMBO J; 2000 Nov; 19(22):6185-95. PubMed ID: 11080164
[TBL] [Abstract][Full Text] [Related]
9. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.
Pearson M; Carbone R; Sebastiani C; Cioce M; Fagioli M; Saito S; Higashimoto Y; Appella E; Minucci S; Pandolfi PP; Pelicci PG
Nature; 2000 Jul; 406(6792):207-10. PubMed ID: 10910364
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
Komura N; Asakawa M; Umezawa K; Segawa K
Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase.
Shin J; Park B; Cho S; Lee S; Kim Y; Lee SO; Cho K; Lee S; Jin BS; Ahn JH; Choi EJ; Ahn K
J Biol Chem; 2004 Sep; 279(39):40994-1003. PubMed ID: 15273249
[TBL] [Abstract][Full Text] [Related]
12. The function of PML in p53-dependent apoptosis.
Guo A; Salomoni P; Luo J; Shih A; Zhong S; Gu W; Pandolfi PP
Nat Cell Biol; 2000 Oct; 2(10):730-6. PubMed ID: 11025664
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
14. PML bodies: a meeting place for genomic loci?
Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
[TBL] [Abstract][Full Text] [Related]
15. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
[TBL] [Abstract][Full Text] [Related]
16. The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage.
Salomoni P; Bernardi R; Bergmann S; Changou A; Tuttle S; Pandolfi PP
Blood; 2005 May; 105(9):3686-90. PubMed ID: 15626733
[TBL] [Abstract][Full Text] [Related]
17. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
Lehembre F; Müller S; Pandolfi PP; Dejean A
Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
[TBL] [Abstract][Full Text] [Related]
19. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
20. Role of PML and the PML-nuclear body in the control of programmed cell death.
Bernardi R; Pandolfi PP
Oncogene; 2003 Dec; 22(56):9048-57. PubMed ID: 14663483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
